Skip to content

TriSalus Life Sciences, Inc. TLSI Other income, net (Note 6)

Other income, net (Note 6) at other companies

AngioDynamics logo
AngioDynamicsANGO
$4.97M-8.5%
InfuSystem Holdings logo
InfuSystem HoldingsINFU
$82K+383%
Delcath Systems logo
Delcath SystemsDCTH
-$58K-1,550%
Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
-$62K+27.1%
Novanta logo
NovantaNOVT
-$73K-911%
United Therapeutics logo
United TherapeuticsUTHR

Other financials

Income statement

See full
Revenue$8.9M-2.9%
Gross profit$7.7M0.0%
Operating income-$8.4M-14.8%
Net income$1.5M+115%
EPS (diluted)$0.03+108%

Balance sheet

See full
Cash & equivalents$56.6M+324%
Total debt$33.1M+4.4%
Total equity$12.8M+137%
Total assets$71.0M+148%

Cash flow

See full
Operating cash flow-$6.5M-44.0%
CapEx$141.0K-81.3%
Free cash flow-$6.6M-26.0%

Valuation

See full
Market cap$279.45M+49.6%
Enterprise value$255.97M+33.6%
P/S6.2×+1.0×

Profitability

See full
Gross margin85.1%-0.5pp
Operating margin-62.4%-16.8pp
Net margin-60.9%-13.4pp
FCF margin-45.2%-16.8pp

Returns & leverage

See full
Return on equity253.3%
Debt / equity2.6×
Current ratio5.8×+3.6×

Where this comes from

Reported directly by TriSalus Life Sciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.

The official record: TriSalus Life Sciences, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about TriSalus Life Sciences, Inc.'s other income, net (note 6).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is TriSalus Life Sciences, Inc.'s other income, net (note 6)?
TriSalus Life Sciences, Inc. (TLSI) reported other income, net (note 6) of -$76K in Q1 2026.
How has TriSalus Life Sciences, Inc.'s other income, net (note 6) changed year-over-year?
TriSalus Life Sciences, Inc.'s other income, net (note 6) increased by 69.7% year-over-year, from -$251K to -$76K.
What is the long-term trend for TriSalus Life Sciences, Inc.'s other income, net (note 6)?
Over 2 years (2023 to 2025), TriSalus Life Sciences, Inc.'s other income, net (note 6) has grown at a 9.7% compound annual growth rate (CAGR), from -$379K to -$456K.
What does other income, net (note 6) mean?
This captures miscellaneous financial items that fall outside the scope of core operating activities, such as foreign exchange gains or losses, minor investment income, or non-recurring legal settlements. It serves as a catch-all for peripheral financial events that do not stem from the primary business operations. Investors monitor this to isolate core earnings from transient or incidental financial fluctuations.